Company Information

CIN
Status
Date of Incorporation
21 November 2005
Listing Status
Unlisted
State
Hyderabad
ROC
ROC Hyderabad
Industry
Pharmaceutical And Botanical Products
Sub Category
Non-govt company
Last Balance Sheet
31 March 2023
Last Annual Meeting
29 April 2023
Paid Up Capital
207,620,880
Authorised Capital
210,000,000
Financials All Documents available from MCA @Rs 499/-

Directors

Sai Prasad Devarajulu
Sai Prasad Devarajulu
Director/Designated Partner
over 1 year ago
Suchitra Ella
Suchitra Ella
Director/Designated Partner
over 4 years ago
Krishna Murthy Ella
Krishna Murthy Ella
Director
over 14 years ago

Past Directors

Ramani Bina Rupkumar
Ramani Bina Rupkumar
Managing Director
almost 18 years ago
Ullmann Ludwig Gustav
Ullmann Ludwig Gustav
Director
over 19 years ago

Registered Trademarks

Rcc Laboratories Rcc Laboratories India

[Class : 42] Research Services Included In Class 42

Rcc Laboratories India Private Limited Rcc Laboratories India

[Class : 42] Clinical Regulatory Operations

Rcc, Linking Science To Progress Rcc Laboratories India

[Class : 42] Clinical Regulatory Operations

Charges

15 Crore
26 March 2012
Citi Bank N.a.
1 Crore
10 March 2021
Technology Development Board
15 Crore
10 March 2021
Others
0
26 March 2012
Citi Bank N.a.
0
10 March 2021
Others
0
26 March 2012
Citi Bank N.a.
0

Documents

Form 66-22032021_signed
Form 66-13022021_signed
Form 66-07012021_signed
Form 66-06012021_signed
Form 66-03012021_signed
Compliance certificate pursuant to rule 3 of the Companies (Compliance Certificate) Rules, 2001-30122020
Compliance certificate pursuant to rule 3 of the Companies (Compliance Certificate) Rules, 2001-29122020
Form ADT-1-28122020_signed
Copy of written consent given by auditor-25122020
Copy of resolution passed by the company-25122020
Form MSME FORM I-17122020_signed
Form DIR-12-29102020_signed
Declaration by first director-28102020
Form MGT-7-19102020_signed
Form AOC-4(XBRL)-17102020_signed
Copy of MGT-8-16102020
XBRL financial statements duly authenticated as per section 134 (including Board's report,auditor's report and other documents)-16102020
XBRL document in respect Consolidated financial statement-16102020
List of share holders, debenture holders;-16102020
Form DPT-3-12082020-signed
Interest in other entities;-26062020
Form DIR-12-26062020_signed
Declaration of the appointee director, Managing director, in Form No. DIR-2;-26062020
Optional Attachment-(1)-26062020
Form DPT-3-06032020-signed
Copy of MGT-8-01112019
List of share holders, debenture holders;-01112019
Form MGT-7-01112019_signed
XBRL financial statements duly authenticated as per section 134 (including Board's report,auditor's report and other documents)-28102019
XBRL document in respect Consolidated financial statement-28102019